Bulletin
Investor Alert

New York Markets Close in:

EyePoint Pharmaceuticals Inc.

NAS: EYPT

GO
/marketstate/country/us

Market open

 --Real time quotes

Sep 29, 2022, 12:29 p.m.

/zigman2/quotes/210537129/composite

$

7.39

Change

-0.27 -3.46%

Volume

Volume 12,082

Real time quotes

/zigman2/quotes/210537129/composite

Previous close

$ 7.65

$ 7.39

Change

-0.27 -3.46%

Day low

Day high

$7.35

$7.65

Open

52 week low

52 week high

$6.91

$21.50

Open

Dario A. Paggiarino

Presently, Dario A. Paggiarino is Chief Medical Officer & Senior Vice President for EyePoint Pharmaceuticals, Inc.

In his past career Dr. Paggiarino occupied the position of President for Angelini Pharmaceuticals Romania SRL, Executive Director-Clinical Development at Pfizer Inc. Clinical Director at Pharmacia Corp. and Executive Director-Clinical Development at Pfizer (St. Louis) (both are subsidiaries of Pfizer Inc.), Chief Development Officer & Senior Vice President at Lpath, Inc. and Vice President at Alcon Laboratories, Inc.

He received a doctorate from Sapienza University of Rome.

Transactions

Date Shares Transaction Value
06/30/2020 12,049   Derivative/Non-derivative trans. at $0.76 per share. 9,158
06/30/2020 41,050   Derivative/Non-derivative trans. at $0 per share. 0
06/27/2020 2,936   Derivative/Non-derivative trans. at $0.79 per share. 2,320
06/27/2020 10,000   Derivative/Non-derivative trans. at $0 per share. 0
06/14/2020 4,168   Derivative/Non-derivative trans. at $0.83 per share. 3,460
06/14/2020 14,200   Derivative/Non-derivative trans. at $0 per share. 0
10/12/2019 2,450   Derivative/Non-derivative trans. at $2.1 per share. 5,145
06/27/2019 2,940   Derivative/Non-derivative trans. at $1.65 per share. 4,851
06/27/2019 10,000   Derivative/Non-derivative trans. at $0 per share. 0
06/14/2019 4,175   Derivative/Non-derivative trans. at $1.53 per share. 6,388
06/14/2019 14,200   Derivative/Non-derivative trans. at $0 per share. 0
03/19/2019 1,188   Derivative/Non-derivative trans. at $2.47 per share. 2,935
10/12/2018 2,455   Derivative/Non-derivative trans. at $3.23 per share. 7,930
10/12/2018 16,667   Award at $0 per share. 0
06/27/2018 2,945   Derivative/Non-derivative trans. at $1.86 per share. 5,478
06/27/2018 10,000   Derivative/Non-derivative trans. at $0 per share. 0
03/19/2018 8,333   Award at $0 per share. 0

Officers and Executives

Dr. Jay S. Duker
Chief Operating Officer
Mr. George O. Elston
CFO & Head-Corporate Development
Dr. Said Saim
Chief Technology Officer
Dr. Dario A. Paggiarino
Chief Medical Officer & Senior Vice President
Ms. Jennifer Leonard
Chief People Officer & Senior Vice President-IT
Mr. Scott Jones
Chief Commercial Officer & Senior Vice President
Mr. Michael C. Pine
Chief Corporate Development & Strategy Officer
Mr. Ye Liu
Director
Dr. Anthony P. Adamis
Director
Ms. Karen L. Zaderej
Director
Mr. Ron I. Honig
Secretary, Chief Legal Officer & Senior VP
Ms. Isabelle Lefebvre
Chief Regulatory Officer
Dr. Göran Albert Torstensson Ando
Non-Executive Chairman
Ms. Wendy F. DiCicco
Independent Director
Dr. John Barry Landis
Independent Director
Dr. David R. Guyer
Independent Director
Link to MarketWatch's Slice.